Mezzion Pharma Co.,Ltd. (KOSDAQ:140410)

Mezzion Pharma Revenue

In the year 2025, Mezzion Pharma had annual revenue of 7.91B KRW, down -8.15%. Mezzion Pharma had revenue of 2.08B in the quarter ending December 31, 2025, with 8.32% growth.

• Revenue: 7.91B
• Revenue Growth: -8.15%
• P/S Ratio: 309.32
• Revenue / Employee: 439.42M
• Employees: 18
• Market Cap: 2.45T

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	7.91B	-702.12M	-8.15%
Dec 31, 2024	8.61B	-23.11B	-72.85%
Dec 31, 2023	31.72B	994.76M	3.24%
Dec 31, 2022	30.73B	4.07B	15.28%
Dec 31, 2021	26.65B	-1.98B	-6.92%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 10, 2026

Data Sources Report a data error